Navigation Links
Pharmos Corporation Reports 2010 Third Quarter Results
Date:10/27/2010

ISELIN, N.J., Oct. 27 /PRNewswire-FirstCall/ -- Pharmos Corporation (Pink Sheets: PARS) today reported financial results for the third quarter and nine-month period ended September 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q which has been filed with the SEC.

During the quarter the Company kept expenses to a minimum level while pursuing potential partners for Dextofisopam, its drug for irritable bowel syndrome diarrhea predominant patients. The Company believes that a Phase 2c trial will be the next step in this compound's development and continues a dialog with potential partners and other sources of capital for that trial. Pharmos is also exploring the potential of S-Tofisopam, an isomer of racemic tofisopam, in several indications in which it has shown signals of activity in prior clinical trials or preclinical models.

Third Quarter Ended September 30, 2010The Company recorded a net loss of $0.5 million, or $0.01 per share, for the third quarter 2010 compared to a net loss of $1.4 million, or $0.03 per share, in the third quarter 2009. Total operating expenses decreased 68% to $0.5 million from $1.4 million. The Company believes that the current cash and cash equivalents, totaling $3.2 million as of September 30, 2010, will be sufficient to support our currently planned continuing operations through at least December 31, 2011.

Research & development expenses decreased by $893,454 from $1,047,260 in 2009 to $153,806 in 2010, related to the Company's completion of the Dextofisopam Phase 2b trial and the downsizing and curtailment of general research and development programs.

General and administrative expenses for the third quarter of 2010 decreased by $46,384 from $342,320 in 2009 to $295,936 in 2010. The primary reductions are in consultant and professional fees, various facility related expenses and salar
'/>"/>

SOURCE Pharmos Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream
2. Pharmos Issues Business Update on Dextofisopam Trial and Financing
3. Pharmos Corporation Reports 2009 Third Quarter Results
4. Pharmos Corporation Reports Fourth Quarter and Full Year 2009 Results
5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
6. CEL-SCI Corporation Releases Letter to Shareholders
7. Alfacell Corporation to Present at UBS Global Life Sciences Conference
8. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
9. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
10. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
11. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Mallinckrodt plc (NYSE: ... Directors has approved a share repurchase program. The open-ended ... million of Mallinckrodt plc ordinary shares. ... remain top priorities as we continue to pursue a ...
(Date:1/22/2015)...  ViewRay™, a privately held medical device company, announced today ... with ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to ... of cancer in Japan . ViewRay,s ... and only MRI-guided radiation therapy system that images and ...
(Date:1/22/2015)... - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a ... cardiovascular disease and overall health is pleased to provide you ... its outlook for 2015 from the CEO, Mr. Eugene ... would like to take this opportunity to share with you ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7
... Science Liaisons (MSLs) have become a key link between the ... that drive marketplace success. And the role of MSLs - ... the coming years as the device industry turns to them ... Given the expanding role of MSLs, it,s critical for organizations ...
... Watson Pharmaceuticals, Inc. (NYSE: WPI ... authorized generic version of PROMETRIUM® (progesterone, USP) Capsules ... with Abbott Laboratories. Watson began shipping the product ... the prevention of endometrial hyperplasia in non hysterectomized ...
Cached Medicine Technology:New Study Examines the Evolving Role of Medical Science Liaisons in the Medical Device Sector 2Watson Launches Generic PROMETRIUM(R) 2
(Date:1/22/2015)... Lynchburg, Va. (PRWEB) January 22, 2015 Liberty ... Health Counseling (M.A.) program from the Council for ... The program, part of Liberty’s Center for Counseling & ... Hawkins, founding dean of the university’s new School of Behavioral ...
(Date:1/22/2015)... 22, 2015 The City of West Hollywood hosted ... to commemorate the 42nd anniversary of the Supreme Court decision Roe ... been 42 years since the Roe vs. Wade decision and the ... present as ever,” said City of West Hollywood Councilmember Abbe Land. ...
(Date:1/22/2015)... Nashville, TN (PRWEB) January 22, 2015 Gabe’s Chemo ... Chemo Duck App, the first app ever created for kids with ... all Apple phones and devices, is filled with enjoyable games to ... life and treatments. The free app helps to keep kids entertained, ...
(Date:1/22/2015)... 2015 VogueQueen is a seasoned and trusted ... many designers are thrilled to have it lead the wedding ... new collection of prom dresses for the global market. , ... strategic vision and he focuses on continuing the goal of ...
(Date:1/22/2015)... January 23, 2015 Angelweddingdress is a famous ... invites its customers to follow it on Facebook, Twitter, and ... Valentine’s Day gift. Angelweddingdress draws a lottery every week. , ... to Feb. 28, 2015. Click Angelweddingdress homepage for ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2
... In celebration of,AARP,s 50th Anniversary and to ... throughout the nation, AARP today,announced the winners of ... more than $1 million nationally to support educational ... and foster,greater civic engagement among students and their ...
... it predicts major episodes, study finds , , WEDNESDAY, April ... young adults can increase their risk of developing depression, ... almost 600 young adults found that those with annual ... gradually increased over two decades, especially among women. In ...
... the extra health-care costs strain the system , , WEDNESDAY, April ... the chances of medical complications during pregnancy, but now a ... the health-care system. , Obese women who are pregnant tend ... more time with their doctors than normal-weight women do. Much ...
... an advance promising to dramatically reduce their dose of ... University School of Medicine in St. Louis have taken ... focused a powerful drug directly on tumors in rabbits ... 1,000 times lower than used previously for this purpose ...
... Arthur J.,Gallagher & Co. today announced the ... Florida. Terms of the transaction,were not disclosed., ... life insurance broker,that provides life insurance programs for ... specialize in arranging premium,financing of large life insurance ...
... To Be Part Of Live Auction At ADA,s ... Ritz-Carlton Dearborn, Donation By Chrysler Jeep Superstores Will Help Children And Teens Attend ... ... and education received a big boost thanks to the generous donation,of a two-year ...
Cached Medicine News:Health News:AARP Legacy Award Celebrates Seaford High School for Innovation in Education 2Health News:AARP Legacy Award Celebrates Seaford High School for Innovation in Education 3Health News:Persistent Insomnia Leads to Depression in Young Adults 2Health News:Obesity During Pregnancy Carries Bigger Price Tag 2Health News:Nano-sized technology has super-sized effect on tumors 2Health News:Nano-sized technology has super-sized effect on tumors 3Health News:Diabetes Research, Advocacy and Education Gets Big Boost with Donation of Two- Year Lease for 2008 Chrysler Sebring Convertible 2
Optical Urethrotome for Telescope 2.7 mm for children....
ACMI urethrotomes are available in two distinct styles to meet your specific professional needs. The Classic Series™ Otis Urethrotome consists of a blade, straight tip, and ball tip, with an av...
New technology in optics, processing and application. Laser-welded mechanics in stainless steel provide high safety in sterilization. Saphire windows distal and proximal, validated even for autoclavi...
... The new OES Pro Cystoscope System incorporates ... urologists the best instruments for diagnostic and ... physicians and nurses to assemble the most ... Pro Cystoscope System incorporates uses stainless steel ...
Medicine Products: